Furthermore mutations in CTNNB1, which encodes Beta-catenin are associated with increased Wnt signaling were identified in ∼ 20% of patients with hepatocellular carcinoma (HCC), including a patient with primary PFIC-2 diagnosis [130]. Here, CTNNB1 is linked to hepatocellular carcinoma.